Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Mitochondrial dysfunction in central nervous system white matter disorders.
More than just multiple sclerosis.
Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis.
Immune Therapy of Multiple Sclerosis - Future Strategies.
Multiple sclerosis: Natalizumab reduces cortical pathology in relapsing-remitting multiple sclerosis.
Could behavioral therapies target specific deficits in multiple sclerosis patients?
1,25-Dihydroxyvitamin D3 Suppresses TLR8 Expression and TLR8-Mediated Inflammatory Responses in Monocytes In Vitro and Experimental Autoimmune Encephalomyelitis In Vivo.
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations.
Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
The role of information system in multiple sclerosis management.
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes.
Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis.
Optic Neuritis, its Differential Diagnosis and Management.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
MicroRNA dysregulation in multiple sclerosis.
Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.

Pages